By next June, pharmaceutical companies in EFPIA member countries, European Federation of Pharmaceutical Industries and Association, will have to disclose their transfers of value with HCPs and HCOs made in 2015. gives an assessment of the situation in Europe: are companies ready for transparency? At what cost?

Read the article:

Disclosure is coming